A recent review, published by assistant professor Suzanne Devkota at Cedars-Sinai Medical Centre in Los Angeles (USA), have shed light on the importance of controlling for external factors in microbiome studies, focusing on medications that could have confounding effects.
A recent study, led by Prof. Peter Holzer from the Research Unit of Translational Neurogastroenterology at Medical University of Graz in Austria, has found that intragastric treatment of mice with an antibiotic mixture impaired novel object recognition. This cognitive effect was associated with a disruption of the microbial communities in the colon, a depletion of bacteria-derived metabolites in the colon, and particular changes of neurochemical brain activity.
What is the current state-of-the-art of faecal microbiota transplantation?
25 Apr 2016by Andreu Prados
Faecal microbiota transplantation has been demonstrated to be a safe and highly effective therapeutic option for refractory C. difficile infection (CDI), and many studies have shown that it may possibly have applications in other illnesses such as inflammatory bowel disease (IBD) and in particular for ulcerative colitis (UC).
A novel review, led by Dr. Andrés Moya from the University of Valencia (Spain) and Dr. Manuel Ferrer from the Institute of Catalysis at Spanish National Research Council in Madrid (Spain), argues that a network-biology approach can help us understand how our gut microbiota is continuously changing in the gut environment.
Unexpected phage-bacteria interactions in a simplified murine gut environment
4 Apr 2016by Joël Doré
In a recent study in PLOS Genetics, investigators wanted to know the impact of prophage carriage in the gastrointestinal tract of monoxenic mice. They studied Escherichia coli bacteria paired with phage λ (both wild-type and mutant strains).
The Gut Microbiota for Health team is happy to present the replay of the plenary sessions of the 5th Gut Microbiota for Health World Summit held in Miami, March 5 & 6, 2016.
Inhibiting age-related inflammation maintains a healthy microbiota and contributes to a longer lifespan in flies
7 Mar 2016by Andreu Prados
A new study, led by Professor Heinrich Jasper from the Buck Institute for Research on Aging in Novato (USA), has found that inhibiting age-related inflammation maintains a healthy gut microbiota and extends lifespan in flies.
A recent study, led by Dr Heping Zhang from the Key Laboratory of Dairy Biotechnology and Bioengineering in China, has reported that early detection of gout may be possible through a diagnosis model that uses gout-associated bacteria.
Live streaming and more: how to participate in the Gut Summit if you can’t make it to Miami
29 Feb 2016by Kristina Campbell
The date of the 2016 Gut Microbiota for Health World Summit is quickly approaching! More than 200 researchers, healthcare professionals and journalists will converge in Miami, Florida (USA) on March 5th and 6th for a unique educational experience focused on gut microbiota.
The estimation that bacterial cells in and on the body outnumber human cells by a ratio of ten to one has been widely cited in both popular media articles and scientific literature. Recently, three scientists from Israel and Canada took it upon themselves to critically examine where this estimate came from and whether it holds true.
